Substance use treatment providers.
Summary
Existing law requires the State Department of Health Care Services to license narcotic treatment programs to use narcotic replacement therapy in the treatment of addicted persons and makes legislative findings in support of coordinated narcotic treatment programs in this regard. Existing law specifies the controlled substances a licensed narcotic treatment program may use for narcotic replacement therapy by licensed narcotic treatment programs, including federally approved, controlled substances used for narcotic treatment. Existing law authorizes the department to approve an office-based narcotic treatment program in a remote site, if certain conditions are met, that include, among others, a physician at a remote site may treat up to a maximum number of 20 patients, who are provided with a specific pharmacological treatment. This bill would add the use of medication-assisted treatment as an authorized service by narcotic treatment programs licensed by the department, and would, in that regard, make legislative findings and declarations that it is in the best interest of the health and welfare of the people of this state to also coordinate medication-assisted treatments for substance use disorders. The bill would modify the specific controlled substances authorized for use by licensed narcotic treatment programs for narcotic replacement therapy and medication-assisted treatment to instead allow medication approved by the federal Food and Drug Administration for the purpose of narcotic replacement treatment or medication-assisted treatment for substance use disorders, and refer to medications, rather than controlled substances, and would authorize the department to implement, interpret, or make specific this provision by means of plan or provider bulletins, or similar instructions and require the department to adopt regulations no later than January 1, 2021. The bill would modify the conditions for the department to authorize an office-based narcotic treatment program in a remote site to authorize a physician to treat a number of patients specified under the United States Drug Enforcement Administration registration and modify the types of authorized pharmacological treatments for narcotic addiction and substance use disorder. The bill would make other conforming changes to related provisions. Existing law establishes the Medi-Cal program, which is administered by the State Department of Health Care Services, under which qualified low-income individuals receive health care services. The Medi-Cal program is, in part, governed and funded by federal Medicaid program provisions. Existing law establishes the Drug Medi-Cal Treatment Program (Drug Medi-Cal) , under which the department is authorized to enter into contracts with each county for the provision of various alcohol and drug treatment services, including substance use disorder services, narcotic treatment program services, naltrexone services, and outpatient drug-free services, to Medi-Cal beneficiaries. Existing law generally requires bills for service under the Medi-Cal program to be submitted not more than 6 months after the month in which the service is rendered. This bill would require bills for services under Drug Medi-Cal to be submitted no later than 6 months from the date of service.
Bill status
signed
all 5 stages cleared
Introduction
Feb 2017
Committee Review
Aug 2017
Assembly Passage
May 2017
Senate Passage
Aug 2017
Signed into Law
Sep 2017
Introduced Feb 9, 2017
Signed Sep 11, 2017
Floor votes · Senate Aug 21, 2017 · Assembly Aug 24, 2017
How they voted
33–1
Passed · 1 other
Total votes 35
Aug 21, 2017
D
Democratic25
100% Yea
R
Republican10
80% Yea
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
27
Key actions
11
Committee
9
Amendments
6
Sep 11, 2017
Signed into law
Approved by the Governor.
legislature
Aug 24, 2017
Assembly · Passed
Assembly Vote: pass (72-0-1)
assembly
Aug 24, 2017
Lower · Passed
Senate amendments concurred in. To Engrossing and Enrolling. (Ayes 78. Noes 0. Page 2754.).
lower
Aug 22, 2017
Introduced
In Assembly. Concurrence in Senate amendments pending. May be considered on or after August 24 pursuant to Assembly Rule 77.
lower
Aug 21, 2017
Senate · Passed
Senate Vote: pass (33-1-1)
senate
Jul 6, 2017
Upper · Passed
Read third time and amended. Ordered to second reading.
upper
Jun 26, 2017
Upper · Passed
From committee: Do pass. (Ayes 6. Noes 0.) (June 26).
upper
Jun 12, 2017
Upper · Passed
Read second time and amended. Re-referred to Com. on APPR.
upper
Jun 8, 2017
Upper · Passed
From committee: Amend, and do pass as amended and re-refer to Com. on APPR. (Ayes 9. Noes 0.) (June 7).
upper
May 18, 2017
Committee
Referred to Com. on HEALTH.
upper
Apr 26, 2017
Lower · Passed
From committee: Do pass. To Consent Calendar. (Ayes 16. Noes 0.) (April 26).
lower
Mar 29, 2017
Lower · Passed
From committee: Do pass and re-refer to Com. on APPR. (Ayes 14. Noes 0.) (March 28). Re-referred to Com. on APPR.
lower
Mar 21, 2017
Committee
Re-referred to Com. on HEALTH.
lower
Mar 20, 2017
Introduced
From committee chair, with author's amendments: Amend, and re-refer to Com. on HEALTH. Read second time and amended.
lower
Mar 6, 2017
Committee
Re-referred to Com. on HEALTH.
lower
Mar 2, 2017
Introduced
From committee chair, with author's amendments: Amend, and re-refer to Com. on HEALTH. Read second time and amended.
lower
Feb 21, 2017
Committee
Referred to Com. on HEALTH.
lower
Feb 10, 2017
Lower · Passed
From printer. May be heard in committee March 12.
lower
0 primary · 0 co-sponsors
Sponsors
No sponsor information available.
Ask Maddy
·
AI policy assistant
Ask Maddy about AB 395
Scope: CA
Hi! I can help you understand AB 395. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline